Nectar Lifesciences Limited has informed the Exchange regarding 'Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015'.
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nectar Lifesciences has submitted a disclosure to the stock exchange under Regulation 7(2) of SEBI's Insider Trading Regulations, 2015. This regulation requires promoters, directors, and key managerial personnel to report their trades in the company's shares to the exchange within two trading days of the transaction. The specific details of the trade — including who traded, whether it was a buy or sell, and the quantity involved — are not included in the headline. Shareholders should refer to the full filing on the NSE website for the actual transaction details.
This is a routine compliance filing required whenever an insider trades in the company's shares. It is informational in nature and on its own does not indicate any material change in the company's fundamentals. Shareholders should check the actual trade details to assess if it signals a change in insider sentiment.